Chemo drug injected into eyes to stop scarring and save sight
NCT ID NCT06425419
Summary
This early-stage trial is testing if a drug called topotecan, injected into the eye during and after surgery, can help prevent a serious complication called proliferative vitreoretinopathy (PVR). PVR causes scarring that can make retinal detachment surgery fail. The study will compare outcomes in about 50 adults who receive the injections to those who do not, checking for safety and whether it reduces the chance of the retina detaching again.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEGMATOGENOUS RETINAL DETACHMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.